Michael H Pourfar
Overview
Explore the profile of Michael H Pourfar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duffley G, Szabo A, Lutz B, Mahoney-Rafferty E, Hess C, Ramirez-Zamora A, et al.
Parkinsonism Relat Disord
. 2023 Mar;
109:105346.
PMID: 36966051
Introduction: Deep brain stimulation (DBS) is an effective treatment for Parkinson's disease (PD), but its efficacy is tied to DBS programming, which is often time consuming and burdensome for patients,...
2.
London D, Fazl A, Katlowitz K, Soula M, Pourfar M, Mogilner A, et al.
Elife
. 2021 Sep;
10.
PMID: 34519273
The subthalamic nucleus (STN) is theorized to globally suppress movement through connections with downstream basal ganglia structures. Current theories are supported by increased STN activity when subjects withhold an uninitiated...
3.
Johnson K, Duffley G, Anderson D, Ostrem J, Welter M, Baldermann J, et al.
Brain
. 2020 Jul;
143(8):2607-2623.
PMID: 32653920
Deep brain stimulation may be an effective therapy for select cases of severe, treatment-refractory Tourette syndrome; however, patient responses are variable, and there are no reliable methods to predict clinical...
4.
Vitek J, Jain R, Chen L, Troster A, Schrock L, House P, et al.
Lancet Neurol
. 2020 May;
19(6):491-501.
PMID: 32470421
Background: Deep brain stimulation (DBS) of the subthalamic nucleus is an established therapeutic option for managing motor symptoms of Parkinson's disease. We conducted a double-blind, sham-controlled, randomised controlled trial to...
5.
Drummond P, Pourfar M, Hill T, Mogilner A, Kondziolka D
Stereotact Funct Neurosurg
. 2020 Feb;
98(2):110-117.
PMID: 32101861
Introduction: Deep brain stimulation (DBS) targeting the subthalamic nucleus (STN) has been shown to reliably improve several symptoms of Parkinson's disease (PD) in appropriately selected patients. Various factors may preclude...
6.
Johnson K, Fletcher P, Servello D, Bona A, Porta M, Ostrem J, et al.
J Neurol Neurosurg Psychiatry
. 2019 May;
90(10):1078-1090.
PMID: 31129620
Background: Deep brain stimulation (DBS) can be an effective therapy for tics and comorbidities in select cases of severe, treatment-refractory Tourette syndrome (TS). Clinical responses remain variable across patients, which...
7.
London D, Pourfar M, Mogilner A
Front Neurosci
. 2019 Apr;
13:270.
PMID: 30983958
Decisions are made through the integration of external and internal inputs until a threshold is reached, triggering a response. The subthalamic nucleus (STN) has been implicated in adjusting the decision...
8.
Pourfar M, Budman C, Mogilner A
Mov Disord Clin Pract
. 2019 Feb;
2(2):192-193.
PMID: 30713894
No abstract available.
9.
Martinez-Ramirez D, Jimenez-Shahed J, Leckman J, Porta M, Servello D, Meng F, et al.
JAMA Neurol
. 2018 Jan;
75(3):353-359.
PMID: 29340590
Importance: Collective evidence has strongly suggested that deep brain stimulation (DBS) is a promising therapy for Tourette syndrome. Objective: To assess the efficacy and safety of DBS in a multinational...
10.
Intraparenchymal Cysts Following Deep Brain Stimulation: Variable Presentations and Clinical Courses
Katlowitz K, Pourfar M, Israel Z, Mogilner A
Oper Neurosurg (Hagerstown)
. 2017 Sep;
13(5):576-580.
PMID: 28922879
Background: The development of cysts at the electrode lead is a rare complication of deep brain stimulation (DBS), with only 3 cases reported in the literature. A better understanding of...